ESC 365 - Prasugrel or clopidogrel in patients with acute coronary syndromes at high thrombotic risk: results from the PROMETHEUS study

ESC Premium Access

Prasugrel or clopidogrel in patients with acute coronary syndromes at high thrombotic risk: results from the PROMETHEUS study

Session: Highlights from the Young in coronary artery disease

Topic: Pharmacotherapy

Speaker: Doctor M. Chiarito (Rozzano, IT)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Mauro Chiarito

Clinical Institute Humanitas IRCCS, Rozzano (Italy)

0 follower

3 more presentations in this session

Cannabis use is associated with prevalent coronary artery disease

Speaker: Doctor N. Patel (Winston-Salem, US)

Dispatch of lay-responders is associated with bystander cardiopulmonary resuscitation, bystander defibrillation and 30-day survival following an out-of-hospital cardiac arrest.

Speaker: Doctor M. Jonsson (Stockholm, SE)

Outcomes of ST-Elevation Myocardial Infarction due to spontaneous coronary artery dissection: a nationwide cohort sample.

Speaker: Doctor A. Elkaryoni (Providence, US)

Access the full session

Highlights from the Young in coronary artery disease

Speakers: Doctor M. Chiarito, Doctor N. Patel, Doctor M. Jonsson, Doctor A. Elkaryoni

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources